SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-016599
Filing Date
2019-08-23
Accepted
2019-08-23 16:16:02
Documents
4
Period of Report
2019-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k081919b_hoththerapeutics.htm 8-K 29737
2 EXCLUSIVE SUBLICENSE AGREEMENT BETWEEN THE COMPANY AND ZYLO THERAPEUTICS, INC. f8k081919bex10-1_hoththerap.htm EX-10.1 166988
3 PRESS RELEASE DATED AUGUST 21, 2019 f8k081919bex99-1_hoththerap.htm EX-99.1 13971
4 GRAPHIC ex99-1_001.jpg GRAPHIC 12181
  Complete submission text file 0001213900-19-016599.txt   228925
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 191049290
SIC: 2834 Pharmaceutical Preparations